Gene expression in mammalian cells and its applications

Advanced Pharmaceutical Bulletin

Volumn 3, Issue 2, 2013, Pages 257-263

  Khan, Kishwar Hayat ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Applications; Expression system; Gene expression; Mammalian cells; Transfection; Vectors

Indexed keywords

ADENOVIRUS VECTOR; BACULOVIRUS VECTOR; FOLLITROPIN; MONOCLONAL ANTIBODY; PLASMID DNA; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; UROKINASE; VACCINIA VECTOR; VIRUS VECTOR;

ANTIBODY PRODUCTION; ARTICLE; CELL ENGINEERING; CELL LINE; ENZYME SYNTHESIS; EXPRESSION VECTOR; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; MAMMAL CELL; NONHUMAN; THYROID HORMONE SYNTHESIS;

EID: 84885782912     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2013.042     Document Type: Article

References (60)

1. Khan KH. Gene Transfer Technologies and their Applications: Roles in Human Diseases. Asian J Exp Biol Sci 2010;1(1):208-18.
2. Khan KH. Gene transfer technologies in plants: roles in improving crops. Recent Res Sci Technol 2009;1(3):116-23.
3. Khan KH. Gene transfer technologies leading to transgenic animals. J Ecobiotechnology 2009; 1(1):32-40.
4. Nettleship JE, Assenberg R, Diprose JM, Rahman-Huq N, Owens RJ. Recent advances in the production of proteins in insect and mammalian cells for structural biology. J Struct Biol 2010;172(1):55-65.
5. Hartley JL. Why proteins in mammalian cells? Methods Mol Biol 2012;801:1-12.
6. Griffin TJ, Seth G, Xie H, Bandhakavi S, Hu WS. Advancing mammalian cell culture engineering using genome-scale technologies. Trends Biotechnol 2007;25(9):401-8.
7. Lee JS, Park HJ, Kim YH, Lee GM. Protein reference mapping of dihydrofolate reductase-deficient CHO DG44 cell lines using 2-dimensional electrophoresis. Proteomics 2010;10(12):2292-302.
8. Wurm FM, Hacker D. First CHO genome. Nat Biotechnol 2011;29(8):718-20.
9. Huh SH, Do HJ, Lim HY, Kim DK, Choi SJ, Song H, et al. Optimization of 25 kDa linear polyethylenimine for efficient gene delivery. Biologicals 2007;35(3):165-71.
10. Boyce FM, Bucher NL. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci U S A 1996;93(6):2348-52.
11. Dukkipati A, Park HH, Waghray D, Fischer S, Garcia KC. BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies. Protein Expr Purif 2008;62(2):160-70.
12. Khandelia P, Yap K, Makeyev EV. Streamlined platform for short hairpin RNA interference and transgenesis in cultured mammalian cells. Proc Natl Acad Sci U S A 2011;108(31):12799-804.
13. Kim JY, Kim YG, Lee GM. CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol 2012;93(3):917-30.
14. Li B, Chu X, Gao M, Xu Y. The effects of CD59 gene as a target gene on breast cancer cells. Cell Immunol 2011;272(1):61-70.
15. Li L, Li B, Zhang H, Bai S, Wang Y, Zhao B, et al. Lentiviral vector-mediated PAX6 overexpression promotes growth and inhibits apoptosis of human retinoblastoma cells. Invest Ophthalmol Vis Sci 2011;52(11):8393-400.
16. De Castilho Fernandes A, Fontes A, Gonsales N, Swiech K, Picanco-Castro V, Faca S, et al. Stable and high-level production of recombinant Factor IX in human hepatic cell line. Biotechnol Appl Biochem 2011;58(4):243-9.
17. Wuest DM, Harcum SW, Lee KH. Genomics in mammalian cell culture bioprocessing. Biotechnol Adv 2012;30(3):629-38.
18. Geisse S, Gram H, Kleuser B, Kocher HP. Eukaryotic expression systems: a comparison. Protein Expr Purif 1996;8(3):271-82.
19. Verma R, Boleti E, George AJ. Antibody engineering: comparison of bacterial, yeast, insect and mammalian expression systems. J Immunol Methods 1998;216(1-2):165-81.
20. Paborsky LR, Fendly BM, Fisher KL, Lawn RM, Marks BJ, Mccray G, et al. Mammalian cell transient expression of tissue factor for the production of antigen. Protein Eng 1990;3(6):547-53.
21. Gorman CM, Gies DR, McCray G. Transient production of proteins using an adenovirus transformed cell line. DNA Prot Eng Tech 1990;2:1-28.
22. Kim DW, Uetsuki T, Kaziro Y, Yamaguchi N, Sugano S. Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 1990;91(2):217-23.
23. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995;3(3):207-20.
24. Berkner KL. Expression of heterologous sequences in adenoviral vectors. Curr Top Microbiol Immunol 1992;158:39-66.
25. Fooks AR, Schadeck E, Liebert UG, Dowsett AB, Rima BK, Steward M, et al. High-level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 1995;210(2):456-65.
26. Massie B, Dionne J, Lamarche N, Fleurent J, Langelier Y. Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. Biotechnology (N Y) 1995;13(6):602-8.
27. De Backer MW, Garner KM, Luijendijk MC, Adan RA. Recombinant adeno-associated viral vectors. Methods Mol Biol 2011;789:357-76.
28. Zhang YF, Moss B. Inducer-dependent conditional-lethal mutant animal viruses. Proc Natl Acad Sci U S A 1991;88(4):1511-5.
29. Pialoux G, Excler JL, Riviere Y, Gonzalez-Canali G, Feuillie V, Coulaud P, et al. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA. AIDS Res Hum Retroviruses 1995;11(3):373-81.
30. Falkner FG, Turecek PL, Macgillivray RT, Bodemer W, Scheiflinger F, Kandels S, et al. High level expression of active human prothrombin in a vaccinia virus expression system. Thromb Haemost 1992;68(2):119-24.
31. Ye L, Xu J, Li S, Liu H, Liu X, Wang Q, et al. [Evaluation and application of exogenous gene expression system based on retroviral vector]. Sheng Wu Gong Cheng Xue Bao 2011;27(8):1225-31.
32. Crockett JC, Mellis DJ, Taylor A. Transfection of osteoclasts and osteoclast precursors. Methods Mol Biol 2012;816:205-22.
33. Lackner A, Kreidl E, Peter-Vorosmarty B, Spiegl-Kreinecker S, Berger W, Grusch M. Stable protein expression in mammalian cells using baculoviruses. Methods Mol Biol 2012;801:75-92.
34. Jardin BA, Elias CB, Prakash S. Expression of a secreted protein in mammalian cells using baculovirus particles. Methods Mol Biol 2012;801:41-63.
35. Chu G, Hayakawa H, Berg P. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res 1987;15(3):1311-26.
36. Jordan M, Wurm FM. Measurable parameters of cells and precipitate predict transfectability with calcium phosphate. In: Merten OW, Perrin P, Griffiths B, Editors. Dordrecht. In New Developments and New Applications in Animal Cell Technology. Netherlands: Kluwer Academic Publishers; 1998. P.125-8.
37. Reece RJ. Analysis of Genes and Genomes. UK: John Wiley and Sons Ltd; 2004.
38. Legendre JY, Trzeciak A, Bohrmann B, Deuschle U, Kitas E, Supersaxo A. Dioleoylmelittin as a novel serum-insensitive reagent for efficient transfection of mammalian cells. Bioconjug Chem 1997;8(1):57-63.
39. Mohan C, Kim YG, Koo J, Lee GM. Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells. Biotechnol J 2008;3(5):624-30.
40. Melton DW, Ketchen AM, Kind AJ, Mcewan C, Paisley D, Selfridge J. A one-step gene amplification system for use in cultured mammalian cells and transgenic animals. Transgenic Res 2001;10(2):133-42.
41. Chu L, Robinson DK. Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol 2001;12(2):180-7.
42. Andersen DC, Reilly DE. Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol 2004;15(5):456-62.
43. Trill JJ, Shatzman AR, Ganguly S. Production of monoclonal antibodies in COS and CHO cells. Curr Opin Biotechnol 1995;6(5):553-60.
44. Rita Costa A, Elisa Rodrigues M, Henriques M, Azeredo J, Oliveira R. Guidelines to cell engineering for monoclonal antibody production. Eur J Pharm Biopharm 2010;74(2):127-38.
45. Roychoudhury PK, Khaparde SS, Mattiasson B, Kumar A. Synthesis, regulation and production of urokinase using mammalian cell culture: a comprehensive review. Biotechnol Adv 2006;24(5):514-28.
46. Keene JL, Matzuk MM, Otani T, Fauser BC, Galway AB, Hsueh AJ, et al. Expression of biologically active human follitropin in Chinese hamster ovary cells. J Biol Chem 1989;264(9):4769-75.
47. Hard K, Mekking A, Damm JB, Kamerling JP, De Boer W, Wijnands RA, et al. Isolation and structure determination of the intact sialylated N-linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells. Eur J Biochem 1990;193(1):263-71.
48. Mannaerts B, De Leeuw R, Geelen J, Van Ravestein A, Van Wezenbeek P, Schuurs A, et al. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology 1991;129(5):2623-30.
49. Cerpa-Poljak A, Bishop LA, Hort YJ, Chin CK, Dekroon R, Mahler SM, et al. Isoelectric charge of recombinant human follicle-stimulating hormone isoforms determines receptor affinity and in vitro bioactivity. Endocrinology 1993;132(1):351-6.
50. Matikainen T, De Leeuw R, Mannaerts B, Huhtaniemi I. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects. Fertil Steril 1994;61(1):62-9.
51. Hakola K, Van Der Boogaart P, Mulders J, De Leeuw R, Schoonen W, Van Heyst J, et al. mbinant rat follicle-stimulating hormone; production by Chinese hamster ovary cells, purification and functional characterization. Mol Cell Endocrinol 1997;127(1):59-69.
52. Schmidt A, Gromoll J, Weinbauer GF, Galla HJ, Chappel S, Simoni M. Cloning and expression of cynomolgus monkey (Macaca fascicularis) gonadotropins luteinizing hormone and follicle-stimulating hormone and identification of two polymorphic sites in the luteinizing hormone beta subunit. Mol Cell Endocrinol 1999;156(1-2):73-83.
53. Minh SD, Below S, Muller C, Hildebrandt JP. Novel mammalian cell lines expressing reporter genes for the detection of environmental chemicals activating endogenous aryl hydrocarbon receptors (ArhR) or estrogen receptors (ER). Toxicol In Vitro 2008;22(8):1935-47.
54. Yin J, Li G, Ren X, Herrler G. Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J Biotechnol 2007;127(3):335-47.
55. Jalah R, Rosati M, Kulkarni V, Patel V, Bergamaschi C, Valentin A, et al. Efficient systemic expression of bioactive IL-15 in mice upon delivery of optimized DNA expression plasmids. DNA Cell Biol 2007;26(12):827-40.
56. Running Deer J, Allison DS. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene. Biotechnol Prog 2004;20(3):880-9.
57. Solomon A, Weiss DT, Wall JS. Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4. Clin Cancer Res 2003;9(10 Pt 2):3831S-8S.
58. Bebbington CR, Renner G, Thomson S, King D, Abrams D, Yarranton GT. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Biotechnology (N Y) 1992;10(2):169-75.
59. Birch JR, Racher AJ. Antibody production. Adv Drug Deliv Rev 2006;58(5-6):671-85.
60. Cacciatore JJ, Chasin LA, Leonard EF. Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system. Biotechnol Adv 2010;28(6):673-81.